Related Experiment Video
Updated: Nov 26, 2025
10:34
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
Published on: November 20, 2021
5.8K
Robotic-assisted versus open total pancreatectomy: a propensity score-matched study.
Yuanchi Weng1, Mengmin Chen1, Georgios Gemenetzis2
1Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Hepatobiliary Surgery and Nutrition
|December 10, 2020
Summary
Robotic-assisted total pancreatectomy (RTP) is safe and feasible in high-volume centers, showing reduced operative times compared to open total pancreatectomy (OTP). Outcomes and quality of life were similar between the two surgical approaches.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Pancreatic Surgery
Background:
- Total pancreatectomy (TP) is a complex procedure with significant morbidity.
- Robotic-assisted surgery offers a minimally invasive approach to TP, but its feasibility is under investigation.
- This study compares robotic-assisted total pancreatectomy (RTP) with conventional open total pancreatectomy (OTP).
Purpose of the Study:
- To assess the safety and efficacy of robotic-assisted total pancreatectomy (RTP).
- To compare perioperative outcomes and quality of life between RTP and open total pancreatectomy (OTP).
Main Methods:
- Retrospective study of patients undergoing TP between March 2015 and July 2019.
- 1:1 propensity score matching (PSM) used to compare RTP and OTP cohorts.
- Data derived from a prospectively maintained institutional database.
Main Results:
- RTP demonstrated significantly decreased operative time compared to OTP [300 min (IQR, 250-360) vs. 360 min (IQR, 300-525), P=0.031].
- Higher rates of en bloc resection and spleen preservation were observed in the RTP cohort.
- Major 30-day morbidity, 90-day mortality, and long-term quality of life were similar between RTP and OTP.
Conclusions:
- Robotic-assisted total pancreatectomy (RTP) is safe and feasible in high-volume centers for specific benign and malignant pancreatic diseases.
- Further prospective randomized studies are warranted to fully establish the feasibility of RTP.
